0.8998USD-3.70%Mkt Cap: 124.11M USDP/E: —Last update: 2026-06-01
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap124.11M USD
Enterprise Value62.66M USD
Revenue (TTM)3.17M USD
Gross Profit3.17M USD
Net Income (TTM)-29.67M USD
Revenue/Share0.0310 USD
Last Price0.8998 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees69
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.13
PEG—
EV/EBITDA-1.85
EV/Revenue19.77
P/S41.25
P/B2.81
EPS (TTM)-0.27
EPS (Forward)-0.23
52W Range
0.387015% of range3.870
52W High3.870 USD
52W Low0.3870 USD
Profitability
Gross Margin100.00%
Oper. Margin-488.23%
EBITDA Margin0.00%
Profit Margin-1817.09%
ROE-89.89%
ROA-50.62%
Growth
Revenue Growth893.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.71M USD
CapEx (TTM)88.00K USD
FCF Margin-106.75%
FCF Yield-2.73%
Net Debt-39.46M USD
Net Debt/EBITDA1.17
Balance Sheet
Debt/Equity0.13
Current Ratio3.40
Quick Ratio3.28
Book Value/Sh0.3380 USD
Cash/Share0.4340 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.500 USD
Target Range5.000 USD – 11.00 USD
# Analysts4
Ownership
Shares Out.112.39M
Float70.78M
Insiders5.01%
Institutions42.21%
Short Interest
Short Ratio9.7d
Short % Float8.22%
Short % Out.7.97%
Shares Short7.96M
Short (prev mo.)9.47M
Technical
SMA 500.9498 (-5.3%)
SMA 2001.149 (-21.7%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)954.22K
Avg Vol (10d)1.34M
Technical Indicators
RSI (14)46.4
MACD0.0039
MACD Signal0.0122
MACD Hist.-0.0083
BB Upper1.146 USD
BB Middle0.9962 USD
BB Lower0.8460 USD
BB Width30.16%
ATR (14)0.0883 USD
Vol Ratio (20d)0.73x